Associates of Cape Cod — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

Associates of Cape Cod, Inc. (ACC) is a specialized life sciences company with a dual focus on industrial quality control and clinical diagnostics. Its core business revolves around manufacturing Limulus Amebocyte Lysate (LAL) and recombinant reagents for bacterial endotoxin testing, alongside the Fungitell® assay for detecting fungal glucans in patient serum. The company demonstrates a strong commitment to sustainability, notably through its Horseshoe Crab Sustainability Project and the development of recombinant alternatives to traditional LAL. With a comprehensive portfolio spanning reagents, software (Pyros® eXpress), instrumentation compatibility, and contract services, ACC serves as an essential partner in ensuring drug safety and aiding in the diagnosis of life-threatening fungal infections.

Infectious DiseaseInvasive Fungal Disease

Technology Platform

Specialized biochemistry platform based on Limulus Amebocyte Lysate (LAL) for endotoxin detection and recombinant DNA technology for sustainable alternatives. Also, a diagnostic platform for detecting (1→3)-β-D-glucan as a biomarker for fungal infections.

Opportunities

Significant growth is driven by the global transition to sustainable, recombinant endotoxin testing reagents and the rising incidence of invasive fungal infections in expanding immunocompromised patient populations.

The trend towards outsourcing specialized quality control and diagnostic testing also presents a major service revenue opportunity.

Risk Factors

Key risks include regulatory compliance challenges in manufacturing, dependence on horseshoe crab populations for traditional LAL, potential supply chain disruptions, and intense competition in both the endotoxin testing and fungal diagnostics markets from established players.

Competitive Landscape

Main competitors include Lonza and Charles River Laboratories in endotoxin testing, with differentiation based on ACC's long heritage, comprehensive service portfolio, and strong sustainability initiatives. In fungal glucan testing, ACC competes with other diagnostic assay providers, leveraging its integrated model of kit manufacturing and CLIA lab services.

More companies in Diagnostics & Precision Medicine →More companies in United States →